Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-β-D-glucan antigens

被引:0
作者
A. Kędzierska
P. Kochan
A. Pietrzyk
J. Kędzierska
机构
[1] Jagiellonian University Medical College,Department of Clinical Microbiology, Chair of Clinical Immunology and Transplantology, Polish
[2] Jagiellonian University Medical College,American Institute of Paediatrics
[3] University Hospital,Chair of Microbiology
来源
European Journal of Clinical Microbiology & Infectious Diseases | 2007年 / 26卷
关键词
Aspergillosis; Invasive Aspergillosis; Invasive Candidiasis; Invasive Pulmonary Aspergillosis; Fusariosis;
D O I
暂无
中图分类号
学科分类号
摘要
Early diagnosis of fungal infections and the implementation of appropriate treatment represent major issues for clinicians, nowadays. Histopathological demonstration of microorganisms in tissue specimens or growth of fungal agents in culture media is still considered the “gold standard”, but obtaining such specimens may be difficult. Several groups have investigated serological assays for cell wall elements unique to fungal organisms in serum or other body fluids to improve diagnostics in patients with haematological malignancies or undergoing haematopoietic stem-cell transplantation. In this review we have concentrated on the currently available assays allowing for detection of highly immunogenic components of fungal cell wall: galactomannan, mannan, and also (1→3)-β-D-glucan. Rapid serological tests appear to be useful for screening high-risk haematological patients, since they allow for the early diagnosis of invasive fungal infections, including infections with the most common pathogens such as Aspergillus and Candida. Based on current literature, factors increasing the probability of obtaining false-positive or false-negative results detected by each test were also analysed and tabulated.
引用
收藏
页码:755 / 766
页数:11
相关论文
共 453 条
  • [1] Enoch DA(2006)Invasive fungal infections: a review of epidemiology and management options J Med Microbiol 55 809-818
  • [2] Ludlam HA(2005)Fungal infections Proc Am Thorac Soc 3 35-40
  • [3] Brown NM(2006)The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study Haematologica 91 1068-1075
  • [4] Kauffman CA(2002)Invasive fungal infection in hematology: new trends Ann Hematol 81 233-243
  • [5] Pagano L(2006)Invasive candidiasis in the intensive care unit Crit Care Med 34 857-863
  • [6] Caira M(2005)Current approaches to diagnosis and treatment of invasive aspergillosis Am J Respir Crit Care Med 173 707-717
  • [7] Candoni A(2007)Trends in the epidemiology of invasive fungal infections Jpn J Med Mycol 48 1-12
  • [8] Offidani M(2003)Epidemiology of J Clin Mcrobiol 41 5525-5529
  • [9] Fianchi L(1994) at a university hospital Clin Infect Dis 18 525-532
  • [10] Martino B(2002)Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis Eur Respir J 19 743-755